Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus.

[1]  R. Rizzi,et al.  Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus , 2009, Journal of cellular and molecular medicine.

[2]  Qian Ren,et al.  Lovastatin restores the function of endothelial progenitor cells damaged by oxLDL , 2009, Acta Pharmacologica Sinica.

[3]  Jian Wang,et al.  Effect of Oxidized Low-density Lipoprotein on Survival and Function of Endothelial Progenitor Cell Mediated by p38 Signal Pathway , 2009, Journal of cardiovascular pharmacology.

[4]  I. Baumgartner,et al.  Oxidized low density lipoprotein impairs endothelial progenitor cell function by downregulation of E-selectin and integrin alpha(v)beta5. , 2008, Biochemical and biophysical research communications.

[5]  A. Zeiher,et al.  High glucose reduces cathepsin L activity and impairs invasion of circulating progenitor cells. , 2008, Journal of molecular and cellular cardiology.

[6]  Hong Yu,et al.  Statin and Stromal Cell‐Derived Factor‐1 Additively Promote Angiogenesis by Enhancement of Progenitor Cells Incorporation into New Vessels , 2008, Stem cells.

[7]  M. Chopp,et al.  Nitric Oxide Donor Upregulation of Stromal Cell‐Derived Factor‐1/Chemokine (CXC Motif) Receptor 4 Enhances Bone Marrow Stromal Cell Migration into Ischemic Brain After Stroke , 2007, Stem cells.

[8]  T. Dai,et al.  Migration of Endothelial Progenitor Cells Mediated by Stromal Cell-Derived Factor-1α/CXCR4 via PI3K/Akt/eNOS Signal Transduction Pathway , 2007, Journal of cardiovascular pharmacology.

[9]  Po-Len Liu,et al.  High Glucose Impairs Early and Late Endothelial Progenitor Cells by Modifying Nitric Oxide–Related but Not Oxidative Stress–Mediated Mechanisms , 2007, Diabetes.

[10]  Jie Du,et al.  Oxidized low-density lipoprotein stimulates p53-dependent activation of proapoptotic Bax leading to apoptosis of differentiated endothelial progenitor cells. , 2007, Endocrinology.

[11]  D. Buerk,et al.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. , 2007, The Journal of clinical investigation.

[12]  K. Bornfeldt,et al.  Do Glucose and Lipids Exert Independent Effects on Atherosclerotic Lesion Initiation or Progression to Advanced Plaques? , 2007, Circulation research.

[13]  Bin Zhou,et al.  Impaired therapeutic vasculogenesis by transplantation of OxLDL-treated endothelial progenitor cells Published, JLR Papers in Press, December 24, 2006. , 2007, Journal of Lipid Research.

[14]  P. Galuppo,et al.  Endothelial Nitric Oxide Synthase Uncoupling Impairs Endothelial Progenitor Cell Mobilization and Function in Diabetes , 2007, Diabetes.

[15]  A. Avogaro,et al.  Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[16]  T. Sawamura,et al.  Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase Published, JLR Papers in Press, March 7, 2006. , 2006, Journal of Lipid Research.

[17]  Stefanie Dimmeler,et al.  Impaired CXCR4 Signaling Contributes to the Reduced Neovascularization Capacity of Endothelial Progenitor Cells From Patients With Coronary Artery Disease , 2005, Circulation research.

[18]  T. Rabelink,et al.  Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress? , 2005, Antioxidants & redox signaling.

[19]  M. Kelm,et al.  Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells , 2005, Thrombosis and Haemostasis.

[20]  Z. Estrov,et al.  Circulating Endothelial Progenitor Cells and Coronary Collaterals in Patients with Non-ST Segment Elevation Myocardial Infarction , 2005, Journal of Vascular Research.

[21]  A. Avogaro,et al.  Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. , 2005, Journal of the American College of Cardiology.

[22]  G. Schuler,et al.  Hyperglycemia Reduces Survival and Impairs Function of Circulating Blood-Derived Progenitor Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[23]  A. Zeiher,et al.  p38 Mitogen-Activated Protein Kinase Downregulates Endothelial Progenitor Cells , 2005, Circulation.

[24]  A. Chait,et al.  Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. , 2004, Diabetes.

[25]  Geoffrey C Gurtner,et al.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.

[26]  T. Sawamura,et al.  OXIDIZED LOW‐DENSITY LIPOPROTEIN INDUCES ENDOTHELIAL PROGENITOR CELL SENESCENCE, LEADING TO CELLULAR DYSFUNCTION , 2004, Clinical and experimental pharmacology & physiology.

[27]  P. Lambiase,et al.  Circulating Humoral Factors and Endothelial Progenitor Cells in Patients With Differing Coronary Collateral Support , 2004, Circulation.

[28]  K. Shimada,et al.  Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease. , 2004, Atherosclerosis.

[29]  K. Shimada,et al.  Predictive value of circulating oxidized LDL for cardiac events in type 2 diabetic patients with coronary artery disease. , 2004, Diabetes care.

[30]  Y. Shang,et al.  Effects of Ox‐LDL on Number and Activity of Circulating Endothelial Progenitor Cells , 2004, Drug and chemical toxicology.

[31]  C. Heeschen,et al.  Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells , 2003, Nature Medicine.

[32]  N. Danchin,et al.  Ischemic heart disease in type 2 diabetes. , 2003, Metabolism: clinical and experimental.

[33]  J. Isner,et al.  Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization , 2003, Circulation.

[34]  Arshed A. Quyyumi,et al.  Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk , 2003 .

[35]  G. Gurtner,et al.  Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures , 2002, Circulation.

[36]  A M Zeiher,et al.  HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. , 2001, The Journal of clinical investigation.

[37]  J. Isner,et al.  HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. , 2001, The Journal of clinical investigation.

[38]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[39]  S. Fichtlscherer,et al.  Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease , 2001, Circulation.

[40]  J. Waltenberger.  Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. , 2001, Cardiovascular research.

[41]  B. Christy,et al.  Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. , 2000, The Journal of clinical investigation.

[42]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[43]  A. Abacı,et al.  Effect of diabetes mellitus on formation of coronary collateral vessels. , 1999, Circulation.

[44]  S. Kawahara,et al.  Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. , 1998, Analytical chemistry.

[45]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[46]  Leelee Ong,et al.  Endothelial NOS is required for SDF-1α/CXCR4-mediated peripheral endothelial adhesion of c-kit+ bone marrow stem cells , 2008, Laboratory Investigation.

[47]  T. Akasaka,et al.  The effect of endothelial progenitor cells on the development of collateral formation in patients with coronary artery disease. , 2008, Internal medicine.

[48]  R. Tran-Son-Tay,et al.  Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. , 2006, Diabetes.

[49]  A. Roguin,et al.  Open Access Cardiovascular Diabetology Nitric Oxide and Superoxide Dismutase Modulate Endothelial Progenitor Cell Function in Type 2 Diabetes Mellitus , 2022 .